111 (YI) Stock Price, News & Analysis

Company Overview

111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, sexual wellness products, and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. In addition, it offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. The company operates offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan provinces. It serves pharmacies, pharmaceutical companies, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.

Key Stats

• Today's Range: $0.60 to $0.64
• 50-Day Range: $0.56 to $1.19
• 52-Week Range: $0.55 to $2.27
• Volume: 90,376 shs
• Average Volume: 132,427 shs
• Market Capitalization: $52.06 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

111 Stock Analysis - MarketRank™

111 scored higher than 24% of companies evaluated by MarketBeat, and ranked 850th out of 963 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for 111.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of 111 is -1.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of 111 is -1.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.04% of the outstanding shares of 111 have been sold short.

Short Interest Ratio / Days to Cover

111 has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in 111 has recently decreased by 56.30%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

111 does not currently pay a dividend.

Dividend Growth

111 does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.04% of the outstanding shares of 111 have been sold short.

Short Interest Ratio / Days to Cover

111 has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in 111 has recently decreased by 56.30%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: N/A

News Sentiment

111 has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.45 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for 111 this week, compared to 5 articles on an average week.

Search Interest

3 people have searched for YI on MarketBeat in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, 111 insiders have not sold or bought any company stock.

Percentage Held by Insiders

43.90% of the stock of 111 is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 21.32% of the stock of 111 is held by institutions.

YI Stock Analysis - Frequently Asked Questions

How have YI shares performed this year?

111's stock was trading at $1.55 on January 1st, 2024. Since then, YI stock has decreased by 60.7% and is now trading at $0.6088.
View the best growth stocks for 2024 here.

How were 111's earnings last quarter?

111, Inc. (NASDAQ:YI) posted its quarterly earnings results on Thursday, August, 29th. The company reported ($0.02) earnings per share for the quarter. The business had revenue of $471.21 million for the quarter.

When did 111 IPO?

111 (YI) raised $140 million in an initial public offering (IPO) on Wednesday, September 12th 2018. The company issued 9,300,000 shares at $14.00-$16.00 per share. J.P. Morgan, Citigroup and CICC acted as the underwriters for the IPO.

How do I buy shares of 111?

Shares of YI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of 111 own?

Based on aggregate information from My MarketBeat watchlists, some other companies that 111 investors own include NVIDIA (NVDA), Teladoc Health (TDOC), Innovative Industrial Properties (IIPR), Magnite (MGNI), Roku (ROKU), Block (SQ) and Twilio (TWLO).

Company Calendar

• Last Earnings: 8/29/2024
• Today: 11/20/2024
• Next Earnings (Confirmed): 11/27/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Drug stores & proprietary stores
• Sub-Industry: Retail
• Current Symbol: NASDAQ:YI
• CUSIP: N/A
• CIK: 1738906
• Web: www.111.com.cn
• Phone: 862120536666
• Fax: N/A
• Employees: 1,520
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.54)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-43,070,000.00
• Net Margins: -2.27%
• Pretax Margin: -2.02%
• Return on Equity: N/A
• Return on Assets: -10.98%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.07
• Quick Ratio: 0.52

Sales & Book Value

• Annual Sales: $2.11 billion
• Price / Sales: 0.02
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.98) per share
• Price / Book: -0.62

Miscellaneous

• Outstanding Shares: 85,520,000
• Free Float: 47,978,000
• Market Cap: $52.06 million
• Optionable: Optionable
• Beta: 0.39